P1 CTU BIOBANK, Canada

Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Registration Status: Completed

Objective: The Phase 1 Clinical Trials Unit (P1 CTU) Biobank is a research biobank established to collect and store blood samples and associated health data from adult participants engaged in studies conducted through the P1 CTU or other research programs within Providence Health Care. Its purpose is to support future ethics‑approved clinical, translational, genetic, and genomic research by enabling the coded, long‑term use of biospecimens and data under appropriate governance and participant consent.

Registered Biobank Name	P1 CTU BIOBANK
Biobank Leader	Naama Rozen
Country	Canada
Email for biobank inquiries	naama.rozen@phc.ca
Principal Investigator	John Boyd
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected: